EMA Transparency Initiative Scandal: EMA Tests No DNA in the Final Product While Violating Fundamental EU Citizens’ Rights Emer Cooke confirmed that the final mRNA vaccines were never tested for residual DNA by EMA and refuses to initiate the standard procedure for EU citizens demanding transparency since months https://drsilviabehrendt751446.substack.com/p/ema-transparency-initiative-scandal?utm_campaign=post&utm_medium=email&triedRedirect=true

Contri: “Il linciaggio mediatico di RFK Jr. orchestrato da Big Pharma” Mentre il cardiologo britannico Aseem Malhotra, vicino a RFK Jr., accusa i vaccini mRNA di aver causato milioni di decessi e di aumentare il rischio di cancro, il nuovo rapporto del Dipartimento della Salute americano rischia di riaccendere il dibattito sulle possibili cause dell'autismo. Intanto Kennedy Jr. affronta un vero linciaggio politico e mediatico al Senato americano. Alberto Contri analizza il clima di delegittimazione e la campagna denigratoria che tenta di silenziare un dibattito scomodo, nell’intervista con Enrica Perucchietti. Contri: “The media lynching of RFK Jr. orchestrated by Big Pharma” While the British cardiologist Aseem Malhotra, close to RFK Jr., accuses mRNA vaccines of having caused millions of deaths and increasing the risk of cancer, the new report from the US Department of Health risks reigniting the debate on the possible causes of autism. Meanwhile, Kennedy Jr. faces a real political and media lynching in the American Senate. Alberto Contri analyzes the climate of delegitimization and the denigration campaign that attempts to silence an uncomfortable debate, in the interview with Enrica Perucchietti. https://youtu.be/I_jiL9YL11A?si=Q5RehngSk2mjPt8P

Il noto immunologo Prof. Robert Clancy, che ha sviluppato il vaccino Broncostat nel 1985, ha curato il COVID con Idrossiclorochina e Ivermectina e afferma che sono efficaci e sono stati deliberatamente vietati perché altrimenti non avrebbero potuto autorizzare i vaccini mRNA. Renowned immunologist Prof. Robert Clancy, who developed the Bronstat vaccine in 1985, treated COVID with Hydroxychloroquine and Ivermectin and says they are effective and were deliberately banned because otherwise they would not have been able to license mRNA vaccines. Source: https://x.com/ChanceGardiner/status/1960572306570236048

DA VEDERE fino IN FONDO e DA CONDIVIDERE! Inside mRNA Vaccines (Subtitles in 31 languages) anche in Italiano! MASSIMA DIFFUSIONE! https://www.youtube.com/watch?v=fDo5-fONeLg

🟰🟰🟰RUSSIA: L'UMANITÀ È STATA SOTTOPOSTA A UN ESPERIMENTO SCONSIDERATO DALLE CONSEGUENZE CATASTROFICHE🟰🟰🟰 https://slaynews.com/news/russia-confirms-mrna-vaccines-triggered-global-cancer-surge/?s=08 Studio russo: https://elib.usma.ru/bitstream/usma/24411/1/USMU_Sbornik_statei_2025_329.pdf

PER NON DIMENTICARE! Gli USA hanno rivelato che i vaccini a mRNA sono più dannosi che utili. In un Paese onesto Mattarella valuterebbe le dimissioni, Draghi e Speranza sarebbero inquisiti, Ronzulli e tanti altri non sarebbero ricandidati. Chiaro? 😡 NOT TO FORGET! The US has revealed that mRNA vaccines are more harmful than helpful. In an honest country Mattarella would consider resigning, Draghi and Speranza would be investigated, Ronzulli and many others would not be re-nominated. Clear? 😡 Source: https://x.com/M25016096/status/1954166460630151229

SHOCK! Il professor Murakami ha analizzato ben 21 milioni di dati vaccinali del Giappone (data vaccinazione, numeri di lotto e decessi) e ha scoperto un inquietante picco di decessi tra i 90 e i 120 giorni dopo la vaccinazione a mRNA, che ha causato la morte di oltre 600.000 persone! Ma, buona notizia, i giapponesi si sono svegliati: da ottobre 2024 solo 10.000 persone si sono fatte inoculare il vaccino ad mRNA replicante contro il covid! L'azienda produttrice ammette che il replicante è più dannoso dei vaccini mRNA di Pizer e Moderna! Eppure in Europa è stata autorizzata la vendita del vaccino replicante Kostaive. L'associazione Citizens United to Stop mRNA Vaccines chiede di unirsi alla lotta internazionale per vietare i "vaccini" ad mRNA! Condividi il link di questo video e ISCRIVITI gratuitamente al canale: https://t.me/dentrolanotizia Se ti piace il video e/o lo trovi utile puoi sostenerci con una donazione singola o MENSILE. Clicca per gli estremi: https://t.me/dentrolanotizia/3203 Grazie! Lo staff di Dentro la Notizia

Buddhist Professor Sucharit Bhakdi: “The ultimate goal is to install mRNA vaccines, for all vaccinations against infectious disease in the world FOREVER”. I'm watching as groups that once had the common goal of preventing this, now fracture and fight each other over missions that they think are the priority. The globalists know exactly how to "divide and conquer" us, by turning us against each other. It's starting to work. Maybe the Globalists will win the war and have mRNA permanently implemented and mandated for future generations of children. Or maybe the people will wake up to the fact that they share a common purpose? As Professor Angus Dalgleish said: “My whole role now is focused on making sure the messenger RNA vaccines never get used for infectious diseases ever again” Professore buddista Sucharit Bhakdi: "L'obiettivo finale è installare vaccini a mRNA, per tutte le vaccinazioni contro le malattie infettive nel mondo, PER SEMPRE". Osservo come gruppi che un tempo avevano l'obiettivo comune di prevenire questo, ora si dividono e si combattono tra loro per missioni che ritengono prioritarie. I globalisti sanno esattamente come "dividerci e conquistarci", mettendoci gli uni contro gli altri. Sta iniziando a funzionare. Forse i globalisti vinceranno la guerra e faranno sì che l'mRNA venga implementato e imposto in modo permanente per le future generazioni di bambini. O forse le persone si renderanno conto di condividere uno scopo comune? Come ha detto il professor Angus Dalgleish: "Tutto il mio ruolo ora è concentrato nell'assicurare che i vaccini a RNA messaggero non vengano mai più utilizzati per le malattie infettive". Source: https://x.com/Humanspective/status/1935817509191684302?t=9DaBP1xn_25l1gVX_3tpCw&s=19

The Business Process as a Service (BPaaS) market is experiencing significant growth, driven by the increasing adoption of cloud-based solutions, the need for operational efficiency, and the rise of digital transformation across industries. This press release provides a country-wise analysis of the BPaaS market, highlighting key trends and developments shaping the industry. The global BPaaS Market size is expected to reach USD 132.83 billion by 2032, according to a new study by Polaris Market Research. Market Overview BPaaS refers to the delivery of business process outsourcing services through cloud-based platforms. It encompasses a wide range of services, including finance and accounting, human resources, procurement, customer service, and supply chain management. BPaaS offers organizations the flexibility to scale operations, reduce costs, and focus on core competencies by outsourcing non-core business functions. Key drivers of BPaaS adoption include: Cost Efficiency: BPaaS eliminates the need for significant upfront investments in infrastructure and software, offering a pay-as-you-go model that reduces operational expenses. Scalability and Flexibility: Cloud-based platforms allow businesses to scale operations quickly and adapt to changing market demands. Access to Advanced Technologies: BPaaS providers leverage technologies such as artificial intelligence, machine learning, and robotic process automation to enhance service delivery and efficiency. Globalization and Market Expansion: BPaaS enables organizations to expand their operations globally without the complexities associated with establishing physical infrastructure in multiple regions. Country-Wise Market Analysis United States The United States is a significant market for BPaaS, driven by: Technological Advancements: The U.S. is at the forefront of adopting cloud technologies and digital transformation initiatives. Large Enterprises: Numerous large enterprises across various sectors are leveraging BPaaS to streamline operations and reduce costs. Regulatory Environment: Favorable regulations and policies support the growth of cloud-based services. India India's BPaaS market is expanding rapidly due to: Skilled Workforce: India offers a large pool of skilled professionals in IT and business process management. Cost Advantage: Competitive labor costs make India an attractive destination for outsourcing business processes. Government Initiatives: Policies promoting digitalization and ease of doing business encourage BPaaS adoption. China China is witnessing growth in the BPaaS market, influenced by: Digital Transformation: Rapid adoption of digital technologies across industries drives the demand for BPaaS solutions. Government Support: Initiatives to promote cloud computing and digital infrastructure boost BPaaS adoption. Large Consumer Market: The vast consumer base creates opportunities for businesses to leverage BPaaS for customer service and engagement. Germany Germany's market is characterized by: Strong Industrial Base: The manufacturing sector's need for efficient supply chain and procurement processes drives BPaaS adoption. Data Privacy Regulations: Strict data protection laws necessitate secure and compliant BPaaS solutions. Innovation Focus: Emphasis on innovation and digitalization in industries such as automotive and engineering. Brazil Brazil's BPaaS market is influenced by: Economic Growth: Expanding economy leads to increased demand for efficient business processes. Digitalization Efforts: Government and private sector initiatives promote digital transformation. Regional Hub: Brazil serves as a gateway for BPaaS services to other Latin American markets. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/bpaas-market Emerging Trends Artificial Intelligence Integration: AI is being integrated into BPaaS solutions to automate tasks, enhance decision-making, and improve customer experiences. Robotic Process Automation (RPA): RPA is increasingly used to automate repetitive tasks, leading to improved efficiency and reduced errors. Industry-Specific Solutions: BPaaS providers are offering tailored solutions to meet the unique needs of industries such as healthcare, finance, and retail. Hybrid Deployment Models: Organizations are adopting hybrid models that combine on-premises and cloud-based BPaaS solutions for greater flexibility. Focus on Data Security: With the increasing reliance on cloud services, data security and compliance are becoming top priorities for BPaaS providers and clients. Conclusion The BPaaS market is poised for substantial growth, driven by technological advancements, the need for operational efficiency, and the rise of digital transformation initiatives across industries. Country-specific factors such as regulatory environments, economic conditions, and technological infrastructure play crucial roles in shaping the market dynamics. Stakeholders in the BPaaS ecosystem must stay abreast of these developments to capitalize on emerging opportunities and navigate potential challenges in the evolving landscape. More Trending Latest Reports By Polaris Market Research: U.S. Non-Automotive Rubber Transmission Belts Market Industrial Hemp Market- update Rapid Oral Fluid Screening Devices Market Automated Material Handling Equipment Market Power Monitoring Market mRNA Vaccines and Therapeutics Market Lawn & Garden Consumables Market Sustainable Finance Market Applicant Tracking System Market

La FDA ammette che i "vaccini" a mRNA per il Covid causano il cancro La Food and Drug Administration (FDA) degli Stati Uniti ha appena fatto l'ammissione esplosiva che i "vaccini" a mRNA Covid sono pieni di contaminazioni che hanno innescato un'ondata globale di tumori. L'agenzia federale ha fatto l'ammissione dopo che uno studio della FDA ha confermato che il "vaccino" a mRNA Covid di Pfizer contiene livelli pericolosi di contaminazione da DNA in eccesso. Come riportato in precedenza da Slay News, i principali scienziati hanno avvertito da tempo che le ondate di tumori mortali tra i vaccinati contro il Covid sono state causate da frammenti di DNA nelle iniezioni di mRNA. Questi avvertimenti sono stati ora confermati in uno studio bomba condotto nel laboratorio della FDA. I test condotti presso il White Oak Campus della FDA nel Maryland hanno rilevato livelli scioccanti di contaminazione del DNA nei "vaccini". I livelli di DNA residuo hanno superato i limiti di sicurezza normativi da 6 a 470 volte. Mentre sei volte il limite di sicurezza sarebbe allarmante, 470 volte è senza precedenti e devastante. Le fiale di vaccino utilizzate durante lo studio provenivano da BEI Resources. BEI è un fornitore di fiducia affiliato al National Institute of Allergy and Infectious Diseases (NIAID), precedentemente guidato dal dottor Anthony Fauci. FDA Admits Covid mRNA “Vaccines” Cause Cancer The US Food and Drug Administration (FDA) just made the explosive admission that Covid mRNA “vaccines” are rife with contamination that has triggered a global wave of cancers. The federal agency made the admission after an FDA study confirmed that Pfizer’s Covid mRNA “vaccine” contains dangerous levels of excess DNA contamination. As Slay News previously reported, leading scientists have long warned that waves of deadly cancers among Covid vaccine recipients were caused by DNA fragments in mRNA injections. Those warnings have now been confirmed in a bombshell study conducted in the FDA’s own lab. Tests conducted at the FDA’s White Oak Campus in Maryland found shocking levels of DNA contamination in the “vaccines.” Levels of residual DNA exceeded regulatory safety limits by 6 to 470 times. While six times the safety limit would be alarming, 470 times is unprecedented and devastating. The vaccine vials used in the study came from BEI Resources. BEI is a trusted supplier affiliated with the National Institute of Allergy and Infectious Diseases (NIAID), formerly led by Dr. Anthony Fauci. 👇👇👇 https://slaynews.com/news/fda-admits-covid-mrna-vaccines-cause-cancer/